Aim: To evaluate the clinical efficacy of Human Urinary kallidinogenase (HUK) in the treatment of acute ischemic stroke (AIS) patients with level 3 hypertension.

Methods: In this retrospective study, from January 2015 to June 2016, 150 consecutive AIS patients were registered in our database. Among them, 47 with level 3 hypertension received either HUK treatment (HUK group, 22 cases) or basic treatment (control group, 25 cases). Basic treatment was administrated on all patients. 0.15 PNA unit of HUK injection plus 100 ml saline in intravenous infusion was performed in the HUK group, with once a day for 14 consecutive days. The modified Rankin Scale (mRS) scores in two groups were analyzed 3 months after the treatment.

Results: No difference was found in the NIHSS scores, age, gender, and comorbidities between two groups before treatment (>.05). While after treatment, 3-month mRS score was significantly lower in the HUK group (2.1 ± 1.4 vs. 3.1 ± 1.3, =.012) and good recovery rate (3-month mRS score ≤2) in the HUK group was significantly higher than that in the control group (<.05).

Conclusion: HUK is able to promote long-term recovery for AIS patients with level 3 hypertension remarkably.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561313PMC
http://dx.doi.org/10.1002/brb3.752DOI Listing

Publication Analysis

Top Keywords

huk group
16
human urinary
8
urinary kallidinogenase
8
good recovery
8
ischemic stroke
8
patients level
8
level hypertension
8
huk treatment
8
ais patients
8
group cases
8

Similar Publications

Background: The relationship between the extent and severity of stress-induced ischemia and the extent and severity of anatomic coronary artery disease (CAD) in patients with obstructive CAD is multifactorial and includes the intensity of stress achieved, type of testing used, presence and extent of prior infarction, collateral blood flow, plaque characteristics, microvascular disease, coronary vasomotor tone, and genetic factors. Among chronic coronary disease participants with site-determined moderate or severe ischemia, we investigated associations between ischemia severity on stress testing and the extent of CAD on coronary computed tomography angiography.

Methods: Clinically indicated stress testing included nuclear imaging, echocardiography, cardiac magnetic resonance imaging, or nonimaging exercise tolerance test.

View Article and Find Full Text PDF

Neuroprotective drugs as adjunctive therapy for adults with acute ischemic stroke (AIS) remains contentious. This study summarizes the latest evidence regarding the benefits of neuroprotective agents combined with intravenous recombinant tissue plasminogen activator (rt-PA) intravenous thrombolysis. This study conducted a structured search of PubMed, the Cochrane Library, EMBASE, Wanfang Data, and CNKI databases from their inception to March 2024.

View Article and Find Full Text PDF

Low-Dose Whole-Chest Dynamic CT for the Assessment of Large Airway Collapsibility in Patients with Suspected Tracheobronchial Instability.

Radiol Cardiothorac Imaging

October 2024

From the Department of Diagnostic and Interventional Radiology, Translational Lung Research Center (TLRC), Subdivision of Pulmonary Imaging, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany (A.B., O.W., R.R., H.U.K., C.P.H., M.O.W.); Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany (A.B., O.W., R.R., H.U.K., F.T., C.P.H., F.J.F.H., M.O.W.); Department of Diagnostic and Interventional Radiology with Nuclear Medicine (A.B., O.W., R.R., H.U.K., C.P.H., M.O.W.) and Department of Pulmonary Medicine (F.T., F.J.F.H.), Thoraxklinik at the University Hospital of Heidelberg, Heidelberg, Germany; Department of Radiology, Division of Pediatric Radiology, Medical University of Graz, Graz, Austria (A.D.); Department of Internal Medicine II, Division of Pulmonology, Medical University of Vienna, Vienna, Austria (D.G.); Department of Pneumology and Critical Care Medicine, Asklepios Klinik Barmbek, Hamburg, Germany (R.E.); and Institute of Medical Informatics, University of Lübeck, Lübeck, Germany (M.H., F.F.).

Article Synopsis
  • - The study aimed to evaluate tracheal collapsibility using low-dose 4D CT, comparing the results with traditional methods like inspiratory-expiratory CT and bronchoscopy in patients suspected of tracheal collapse.
  • - Researchers analyzed 4D CT scans from 52 patients, finding that 48% exhibited significant tracheal collapsibility (50% or greater) and noted differences between visual 4D CT assessments and other diagnostic methods regarding detection rates of collapsibility.
  • - Results showed that 4D CT was superior in identifying patients with severe collapsibility compared to both paired CT and bronchoscopy, with significant differences in collapsibility measurements between the groups assessed.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze and compare the endometrial echogenicity and heterogeneity in healthy and diseased bitches using ultrasound and digital tools, focusing on conditions like pyometra, cystic endometrial hyperplasia (CEH), and endometritis.
  • It involved 41 intact post-pubertal bitches, categorized by their uterine conditions, and utilized ImageJ software to measure echogenicity and heterogeneity through mean gray value (MGV) and standard deviation of gray (SDG).
  • Results indicated that pyometra had significantly higher MGV and SDG than other conditions, while no significant differences were observed among CEH, endometritis, and
View Article and Find Full Text PDF

Objective: Investigate the feasibility of detecting early treatment-induced tumor tissue changes in patients with advanced lung adenocarcinoma using diffusion-weighted MRI-derived radiomics features.

Methods: This prospective observational study included 144 patients receiving either tyrosine kinase inhibitors (TKI, n = 64) or platinum-based chemotherapy (PBC, n = 80) for the treatment of pulmonary adenocarcinoma. Patients underwent diffusion-weighted MRI the day prior to therapy (baseline, all patients), as well as either + 1 (PBC) or + 7 and + 14 (TKI) days after treatment initiation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!